This is an advanced fifth-year level program of one-year duration (possible 2 with one year of research). Each year, one to two new fellows are selected to begin training in July. To be considered for the MD Anderson Cancer Anesthesia fellowship, all candidates must have completed an accredited Anesthesiology residency program in either the United States or Canada and be board certified or board eligible. International candidates with equivalent foreign training will be considered if they have full ECFMG certification.
In addition to the application documents for all candidates, international candidates will also need to have the following: An appropriate J-1 visa, which allows for work/training, ECFMG certification (this is also a requirement for the visa), certified translations for all documents that are not in English, a credentials evaluation which states that their foreign medical degree is comparable to ones that are issued by an accredited US medical school, and a Physician-in-Training (PIT) permit of full medical license from the Texas Medical Board.
Successful completion of fellowship training results in an institutional certification by MD Anderson. In order to be qualified for certification, the fellow must complete 12 months of training within the department. Fellows will have to customize clinical rotations in surgical oncology, head and neck oncology, brain tumors, acute and chronic pain, pulmonary lab and research (2 - 3 months). Clinical or laboratory research is encouraged during the fellowship.
- Fellows attend the institutional GME competency and Oncology core curriculum lecture series
- Fellows have the opportunity to participate in the workshops/conferences sponsored by the department for national audience
- Fellows are strongly encouraged to attend the educational sessions for Fellows in Surgical Oncology, Neurosurgery and Thoracic Surgery
- It is anticipated that the Fellow upon completion of the training will be eligible and ready to enter into the i-TEE certification program
1. Cata JP, Guerra C, Soto G, Ramirez MF. Anesthesia Options and the Recurrence of Cancer: What We Know so Far? Local and regional anesthesia. 2020;Volume 13:57-72.
2. Cata JP, Guerra CE, Chang GJ, Gottumukkala V, Joshi GP. Non-steroidal anti-inflammatory drugs in the oncological surgical population: beneficial or harmful? A systematic review of the literature. Br J Anaesth. 2017;119(4):750-764.
3. Soliz JM, Ifeanyi IC, Katz MH, et al. Comparing Postoperative Complications and Inflammatory Markers Using Total Intravenous Anesthesia Versus Volatile Gas Anesthesia for Pancreatic Cancer Surgery. Anesth Pain Med. 2017;7(4):e13879.
4. Cata JP, Bhavsar S, Hagan KB, et al. Intraoperative serum lactate is not a predictor of survival after glioblastoma surgery. J Clin Neurosci. 2017;43:224-228.
5. Cata JP, Bhavsar S, Hagan KB, et al. Scalp blocks for brain tumor craniotomies: A retrospective survival analysis of a propensity match cohort of patients. J Clin Neurosci. 2018;51:46-51.
6. Cata JP, Hagan KB, Bhavsar SD, et al. The use of isoflurane and desflurane as inhalational agents for glioblastoma surgery. A survival analysis. J Clin Neurosci. 2017;35:82-87.
7. Grasu RM, Cata JP, Dang AQ, et al. Implementation of an Enhanced Recovery After Spine Surgery program at a large cancer center: a preliminary analysis. J Neurosurg Spine. 2018;29(5):588-598.
8. Cata JP, Chavez-MacGregor M, Valero V, et al. The Impact of Paravertebral Block Analgesia on Breast Cancer Survival After Surgery. Reg Anesth Pain Med. 2016;41(6):696-703.
9. Cata JP, Nguyen LT, Ifeanyi-Pillette IC, et al. An assessment of the survival impact of multimodal anesthesia/analgesia technique in adults undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a propensity score matched analysis. Int J Hyperthermia. 2019;36(1):369-375.
10. Lasala JD, Heir JS, Mena GE, et al. Implementation of an Enhanced Surgical Recovery Programme (ESRP) in gynaecologic oncology: Has the development of a preoperative order set improved compliance for preventive analgesia and deep venous thromboembolic (DVT) prophylaxis? Clin Nutr ESPEN. 2016;12:e44.
11. Lasala JD, Heir JS, Mena GE, et al. Impact of an Enhanced Surgical Recovery Programme (ESRP) on postoperative renal function: Is euvolemia ideal for all or only a select few? Clin Nutr ESPEN. 2016;12:e43.
All applications materials should be addressed to:
Juan P. Cata, M.D.
Associate Professor and Cancer Anesthesia Fellowship Program Director
Department of Anesthesiology & Perioperative Medicine
The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Houston, TX 77030-4009
Mary Ann Oler
Program Coordinator, Education
Division of Anesthesiology, Critical Care, & Pain Medicine
1515 Holcombe Blvd, Unit 0112
Houston, TX 77030-4009
Rotating Resident Information
UT Health Science Center Residents in their CA-II and CA-III years may rotate for 1 month with the Thoracic Anesthesia Service at MD Anderson. This provides a unique opportunity to care for cancer patients undergoing a wide variety of Thoracic surgeries. Our faculty also staff Urologic and Gynecologic surgeries. You may be assigned to these cases when deemed educationally appropriate (IVC thrombectomy).
The goals and objectives for rotating residents are as follows:
- Functional anatomy and physiology of the human airway
- Recognition and classification of the difficulty, analysis, explanation and application of the American Society of Anesthesiologists Difficult Airway Algorithm
- Adaptation of this algorithm to patients requiring one-lung ventilation
- Application of video-laryngoscopy, fiberoptic bronchoscopy and video-DLT
- Case examples and analysis with the opportunity to author posters, abstracts and manuscripts as opportunities occur
- Preoperative evaluation & intraoperative management
- TEG versus Quantra determination of clotting factors
Anesthesia for Thoracic surgery
- Preoperative evaluation
- PFT, Lung split function test and CT
- Intraoperative monitoring
- Physiology of one-lung ventilation and lateral decubitus position
- Methods to achieve lung isolation/one-lung ventilation
- DLTs and bronchial blockers (types and sizing)
- High frequency jet ventilation
- Management of one-lung ventilation
- Anesthetic considerations for Thoracic surgery
- Open, thoracoscopic and robotic
- Wedge resection, lobectomy and pneumonectomy
- Extra pleural pneumonectomy and pleurectomy
- Sleeve and tracheal resection & reconstruction
- Sarcoma resection and vascular reconstruction
- Chest-wall resection & reconstruction
- Intra-thoracic fistula repair
- Cardiac tumors
Anesthesia for diagnostic procedures
- Fiberoptic and rigid bronchoscopy
- Thoracic epidural
- ERAS for Thoracic surgery
- TEE (basic intermediate and advance level)
- Postoperative management and complications
- Placement of arterial line, central venous access and pulmonary artery catheter
MD Anderson Cancer Center is committed to encouraging good health and staying true to our mission to end cancer. If you are applying for a GME fellowship or residency program starting on or after July 1, 2016, please be advised that MD Anderson will have instituted a tobacco-free hiring process as part of its efforts to achieve these goals. If you are offered an appointment, you will be subject to a Pre-Employment Drug Screen for tobacco compounds in compliance with applicable state laws. If you do not pass the urine drug screening which includes testing for tobacco compounds, you CANNOT be appointed at MD Anderson. Should you fail to meet this contingency, MD Anderson will withdraw your offer of appointment for the academic year. You may reapply for the following academic year, but there are no guarantees that you will be offered a position as many of our programs are already filled for several years out.